Skip to main content
. 2013 Apr 19;62(6):1083–1091. doi: 10.1007/s00262-013-1407-9

Fig. 2.

Fig. 2

Increased MDSC in the spleens and tumors of Panc02 tumor–bearing mice. a Spleens (n = 4 per group) were collected from naïve and Panc02 tumor–bearing mice on days 14, 20, 24, and 27 after Panc02 injection. b CD11b+Gr1+ MDSC percentages in the tumors of mice on days 20, 24, and 27 after injection of Panc02 tumor. CD11b+Gr1+ cells were measured by flow cytometry

HHS Vulnerability Disclosure